Tscan Therapeutics Inc (TCRX) is a biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell therapies for the treatment of cancer. The company’s proprietary platform identifies novel TCR targets and engineers TCRs directed against these targets for use in TCR-T cell therapies. These therapies aim to harness the power of the […]
Read MoreCardiff Oncology Inc. (CRDF) is a clinical-stage biotechnology company focused on developing novel treatments for cancer. The company’s primary objective is to leverage its expertise in oncology and drug development to create therapies that can address unmet medical needs and improve the lives of patients battling cancer. Three main drivers of growth for Cardiff Oncology […]
Read MoreJanux Therapeutics Inc (JANX) is a biopharmaceutical company focused on developing innovative cancer immunotherapies. The company aims to harness the power of the immune system to target and eliminate cancer cells. Their approach involves creating novel therapeutics that can stimulate the body’s immune response against tumors, potentially leading to improved outcomes for patients with various […]
Read MoreVerastem, Inc. (VSTM) is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company was founded in 2010 and is headquartered in Needham, Massachusetts. Verastem’s mission is to improve the lives of patients suffering from cancer by targeting the underlying biology of cancer stem cells, […]
Read MoreNkarta Inc (NKTS) is a biotechnology company focused on the research, development, and commercialization of natural killer (NK) cell therapies for the treatment of cancer. NK cells are a type of immune cell that can identify and destroy cancerous or infected cells in the body. Nkarta’s innovative approach involves harnessing and enhancing the innate power […]
Read MoreImmunome, Inc. (IMNM) is a biopharmaceutical company primarily engaged in discovering and developing antibody therapeutics. The company focuses on treatments for oncology and infectious diseases. Its lead oncology program is IMM-ONC-01, which targets IL-38, a tumor-derived immune checkpoint that helps tumors evade the immune system. Additionally, Immunome is developing IMM-BCP-01, an antibody cocktail aimed at […]
Read MoreFingerMotion, Inc. (FNGR) FingerMotion, Inc., a mobile data specialist company, provides mobile payment and recharge platform system in China. Nuvalent, Inc. (NUVL) Nuvalent, Inc., a clinical stage biopharmaceutical company, engages in the development of therapies for patients with cancer. Immunovant, Inc. (IMVT) Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of […]
Read MoreNo matter how much the world moves away from COVID-19, the truth is that it isn’t going away. The move by government entities as well as healthcare organizations around the world to “endemic” phase protocols doesn’t mean the disease has been eradicated. It really means that the disease is acknowledged as a permanent part of […]
Read MoreOncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. ONCY $1.7400 0.1300 % 8.0700 Oncolytics Biotech Inc Sector : Medical Industry : Medical – Biomedical Signal Short Term Trend Long Term Trend BUY UP UP Day: 8.07% Wk: 7.41% Mo: 48.72% Yrly: 55.36% […]
Read MoreNo matter how tired we get of hearing about COVID-19, there is no denying that ever since the virus found its way to American shores more than two years ago, a lot of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names […]
Read MoreCTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. CTIC $4.9300 0.1200 % 2.4900 Cti Biopharm Corp […]
Read MoreAs I’ve studied the market over the years, one of the intriguing contrasts comes in the way different analysis methods take in the “big picture” of the market. That includes the way that fundamental investors and analysts look at the market versus those that prefer to work on strictly technical terms. I like to work […]
Read MoreAehr Test Systems (AEHR) Aehr Test Systems primarily designs, engineers, manufactures, and sells test and burn-in equipment for use in the semiconductor industry in North America, Asia, and Europe. It provides full wafer contact test systems, test during burn-in systems, test fixtures, and related accessories. The company offers Advanced Burn-in and Test System family of […]
Read MoreAs recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]
Read MoreBuy Price: $4.40 or better Sell Price: TradersPro Sell Signal Immutep Limited, a biotech company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its principal product candidate is IMP321, also known as Âeftilagimod alpha’ or Âefti’, which is a recombinant […]
Read More